Lunai Bioworks Inc.
LNAI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $129 | $0 | $0 | $0 |
| Gross Profit | -$129 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $537 | $2,709 | $4,165 | $8,373 |
| G&A Expenses | $17,880 | $24,558 | $15,318 | $14,330 |
| SG&A Expenses | $17,880 | $24,558 | $15,318 | $14,330 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $170,549 | $54,373 | $19,073 | $93,377 |
| Operating Expenses | $188,966 | $81,639 | $38,557 | $116,079 |
| Operating Income | -$188,966 | -$81,639 | -$38,557 | -$116,079 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $10,959 | -$6,787 | -$1,127 | $2,646 |
| Pre-Tax Income | -$178,007 | -$88,426 | -$39,684 | -$113,433 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$178,007 | -$88,426 | -$39,684 | -$113,433 |
| % Margin | – | – | – | – |
| EPS | -10.78 | -9.1 | -7.1 | -21.6 |
| % Growth | -18.5% | -28.2% | 67.1% | – |
| EPS Diluted | -10.78 | -9.1 | -7.1 | -21.6 |
| Weighted Avg Shares Out | 16,506 | 9,751 | 5,627 | 5,253 |
| Weighted Avg Shares Out Dil | 16,506 | 9,751 | 5,627 | 5,253 |
| Supplemental Information | – | – | – | – |
| Interest Income | $116 | $0 | $0 | $122 |
| Interest Expense | $726 | $2,435 | $707 | $373 |
| Depreciation & Amortization | $129 | $122 | $113 | $124 |
| EBITDA | -$177,153 | -$85,869 | -$38,864 | -$112,937 |
| % Margin | – | – | – | – |